Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials Jennifer G. Le-Rademacher, PhD, Elizabeth M. Storrick, BA, Aminah Jatoi, MD, Sumithra J. Mandrekar, PhD Mayo Clinic Proceedings: Innovations, Quality & Outcomes Volume 3, Issue 2, Pages 176-182 (June 2019) DOI: 10.1016/j.mayocpiqo.2019.01.002 Copyright © 2019 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure 1 Confidence in accuracy of adverse event attribution (N=60). Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2019 3, 176-182DOI: (10.1016/j.mayocpiqo.2019.01.002) Copyright © 2019 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure 2 A, Team members consulted when assigning attribution (percent response of 60 responders; responders can select multiple responses). B, Information used to determine attribution (percent response of 60 responders; responders can select multiple responses). C, Suggested effective training for adverse event attribution (percent response of 60 responders; responders can select multiple responses). Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2019 3, 176-182DOI: (10.1016/j.mayocpiqo.2019.01.002) Copyright © 2019 Mayo Foundation for Medical Education and Research Terms and Conditions